Staar Surgical (STAA) Non-Current Deffered Revenue (2015 - 2026)

Staar Surgical (STAA) reported Non-Current Deffered Revenue of $89000.0 for Q2 2026, little changed quarter-over-quarter from $89000.0 in Q1 2026.

Staar Surgical (STAA) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends

Staar Surgical has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $89000.0 in Q2 2026.

For the quarter ending Q2 2026, Non-Current Deffered Revenue changed N/A year-over-year to $89000.0; the trailing twelve-month figure through Apr 2026 stood at $89000.0 (changed N/A YoY), and the FY2026 full-year result was $89000.0, changed N/A from the prior year.
Non-Current Deffered Revenue for Q2 2026 stood at $89000.0, roughly flat from $89000.0 in the prior quarter.
The five-year high for Non-Current Deffered Revenue was $89000.0 in Q3 2025, with the low at $89000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Deffered Revenue (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	-
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	163.15 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	11.80 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	-
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	208.80 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	-
10	Staar Surgical	1.44 Bn	1.27 Bn	68.86 Mn	89,000.00

Download Data